https://pubmed.ncbi.nlm.nih.gov/32445440/
Conclusions: Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection. (Funded by the National Institute of Allergy and Infectious Diseases and others; ACCT-1 ClinicalTrials.gov number, NCT04280705.).
Analysis of Heme Iron Coordination in DGCR8: The Heme-Binding Component of the Microprocessor Complex
- PMID: 27546061
- DOI: 10.1021/acs.biochem.6b00204
Hazel M. Girvan†, Justin M. Bradley‡, Myles R. Cheesman‡, James R. Kincaid§, Yilin Liu§, Kazimierz Czarnecki§, Karl Fisher†, David Leys†, Stephen E. J. Rigby†, and Andrew W. Munro*†
View Author Information
Cite this: Biochemistry 2016, 55, 36, 5073–5083
Publication Date:August 20, 2016
RNA-virus encoded microRNA
May 25, 2020
Aftermaths of Cyclone Amphan 24.5. 2020
May 24, 2020
OCHA Reliefweb Aftermaths of Cyclone Amphan
May 23, 2020
COVID-19 and hydroxychloroquine
May 17, 2020
https://www.ncbi.nlm.nih.gov/pubmed/32402766
Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.